Regulatory requirements for reduced exposure and modified risk tobacco products are evolving across the globe, and submissions to regulatory authorities are a part of this changing environment.
Celerion has experience in working with the FDA, as well as other regulatory bodies including the EMA and MHRA. Leveraging our regulatory experience and familiarity with the tobacco industry, allows us to assist clients as they navigate the evolving regulatory pathway toward product approval.
Our focus at Celerion is to keep abreast of regulatory changes, by attending and actively participating in public FDA Centre for Tobacco Products (CTP) meetings, and sharing our experience in the field of tobacco research.
Read more about the FDA Guidance, Regulations and Compliance.